Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk NVO we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 71% of the investors opened trades with bullish expectations and 28% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $201,386 and 16, calls, for a total amount of $1,105,756.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $52.5 to $120.0 for Novo Nordisk over the last 3 months.
Volume & Open Interest Development
In today's trading context, the average open interest for options of Novo Nordisk stands at 1078.84, with a total volume reaching 5,467.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Novo Nordisk, situated within the strike price corridor from $52.5 to $120.0, throughout the last 30 days.
Novo Nordisk Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | TRADE | BULLISH | 04/17/25 | $2.65 | $2.55 | $2.65 | $90.00 | $291.5K | 1.8K | 1.1K |
| NVO | CALL | SWEEP | BULLISH | 01/16/26 | $17.85 | $17.8 | $17.85 | $70.00 | $183.8K | 224 | 106 |
| NVO | CALL | TRADE | BULLISH | 04/17/25 | $3.95 | $3.85 | $3.91 | $85.00 | $97.7K | 1.0K | 172 |
| NVO | CALL | SWEEP | BULLISH | 02/21/25 | $3.9 | $3.85 | $3.85 | $80.00 | $80.4K | 661 | 1.0K |
| NVO | CALL | TRADE | BULLISH | 04/17/25 | $12.2 | $12.05 | $12.15 | $70.00 | $60.7K | 47 | 56 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Novo Nordisk's Current Market Status
- With a trading volume of 13,377,152, the price of NVO is down by -5.35%, reaching $78.63.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 19 days from now.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
